4.4 Article

Efficacy of Anti-Interleukin-1 Receptor Antagonist Anakinra (Kineret (R)) in a Case of Refractory Sweet's Syndrome

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome

Ioannis Mitroulis et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2010)

Review Dermatology

Neutrophilic Dermatoses A Review of Current Treatment Options

Philip R. Cohen

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2009)

Letter Rheumatology

Etanercept Treatment in Sweet's Syndrome with Inflammatory Arthritis

Nicola L. Ambrose et al.

JOURNAL OF RHEUMATOLOGY (2009)

Letter Rheumatology

Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome

A. Delluc et al.

ANNALS OF THE RHEUMATIC DISEASES (2008)

Article Ophthalmology

Sweet Syndrome Presenting as Resistant Conjunctivitis

Guillaume Michel et al.

CORNEA (2008)

Review Rheumatology

Primer: inflammasomes and interleukin 1 beta in inflammatory disorders

Leigh D. Church et al.

NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)

Letter Gastroenterology & Hepatology

Sweet syndrome associated with ulcerative colitis

Anna Paula Rocha Malheiros et al.

INFLAMMATORY BOWEL DISEASES (2007)

Letter Gastroenterology & Hepatology

Coexistence of pyoderma gangrenosum and sweet's syndrome in a patient with ulcerative colitis

Manuel Castro-Fernandez et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)